Linden Thomas Advisory Services LLC Has $685,000 Holdings in Transcat, Inc. (NASDAQ:TRNS)

Linden Thomas Advisory Services LLC raised its position in Transcat, Inc. (NASDAQ:TRNS) by 23.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,477 shares of the scientific and technical instruments company’s stock after buying an additional 1,219 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Transcat were worth $685,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC boosted its position in Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after buying an additional 137,830 shares in the last quarter. Millrace Asset Group Inc. acquired a new position in Transcat in the third quarter valued at about $655,000. Champlain Investment Partners LLC boosted its position in Transcat by 22.1% in the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock valued at $49,455,000 after buying an additional 74,169 shares in the last quarter. State Street Corp boosted its position in Transcat by 8.1% in the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock valued at $25,027,000 after buying an additional 15,514 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its position in Transcat by 64.0% in the third quarter. BNP Paribas Financial Markets now owns 22,661 shares of the scientific and technical instruments company’s stock valued at $2,737,000 after buying an additional 8,844 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Price Performance

TRNS opened at $99.50 on Monday. The company has a market cap of $915.40 million, a price-to-earnings ratio of 50.25 and a beta of 0.71. The firm has a 50 day simple moving average of $105.40 and a 200 day simple moving average of $115.59. Transcat, Inc. has a fifty-two week low of $94.29 and a fifty-two week high of $147.12.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). The business had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. The company’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period last year, the firm earned $0.41 earnings per share. As a group, analysts expect that Transcat, Inc. will post 2.44 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on TRNS. Craig Hallum upped their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Northland Securities reduced their target price on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research report on Wednesday, October 30th. HC Wainwright reiterated a “buy” rating and set a $156.00 target price on shares of Transcat in a research report on Tuesday, October 29th. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. Finally, Oppenheimer reiterated an “outperform” rating and set a $130.00 target price (down from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $130.25.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.